All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36560780

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36560780	G946V	S	S	COVID-19		View
2	36560780	C1243F	S	S	COVID-19		View
3	36560780	T307I	S	S	COVID-19		View
4	36560780	E583D	S	S	COVID-19		View
5	36560780	A647S	S	S	COVID-19		View
6	36560780	R683Q	S	S	COVID-19		View
7	36560780	H655Y	S	S	COVID-19		View
8	36560780	P681H	S	S	COVID-19		View
9	36560780	V1104L	S	S	COVID-19		View
10	36560780	A684V	S	S	COVID-19		View
11	36560780	D614G	S	S	COVID-19		View
12	36560780	L84S	ORF8	ORF8	COVID-19		View
13	36560780	Q57H	ORF3a	ORF3a	COVID-19		View
14	36560780	P314L	ORF1b	ORF1b	COVID-19		View
15	36560780	Y1464C	ORF1b	ORF1b	COVID-19		View
16	36560780	P1427L	ORF1b	ORF1b	COVID-19		View
17	36560780	T265I	ORF1a	ORF1a	COVID-19		View
18	36560780	L176F	NTD	S	COVID-19		View
19	36560780	P323L	NSP12	ORF1b	COVID-19		View
20	36560780	S183Y	N	N	COVID-19		View
21	36560780	S194L	N	N	COVID-19		View
22	36560780	G204R	N	N	COVID-19		View
23	36560780	N203R	N	N	COVID-19		View
24	36560780	P71L	E	E	COVID-19		View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.